Feed Preview

Fast Growing

Inflammatory Breast Neoplasms

Inflammatory Breast Neoplasms diagram by David A. Litman, Shutterstock
David A. Litman, Shutterstock

Inflammatory breast cancer is a rare disease characterized by edema and redness of the breast. This is caused by metastatic breast cancer cells blocking lymphatic vessels. Discover the latest research on Inflammatory breast cancer here.

Top 20 most recent papers

Tuft cells restrain pancreatic tumorigenesis through paracrine eicosanoid signaling

bioRxivDecember 20, 2019
Kathleen E. DelGiornoGeoffrey M. Wahl
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology

Strict definition of inflammatory breast cancer should be revisited

Journal of B.U.ON. : Official Journal of the Balkan Union of OncologyJanuary 27, 2020
Kadri Altundag
Anti-cancer Agents in Medicinal Chemistry

The Anticancer Properties of Silibinin: its Molecular Mechanism and Therapeutic Effect in Breast Cancer

Anti-cancer Agents in Medicinal ChemistryDecember 21, 2019
Binienda AgataPluciennik Elzbieta
Bratislavské lekárske listy

STAT3 expression is correlated with pathological stage in luminal subtypes of breast carcinoma

Bratislavské lekárske listyJanuary 18, 2020
M ErogluS H Kirimlioglu
Breast Cancer Research and Treatment

Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity

Breast Cancer Research and TreatmentFebruary 12, 2020
Charlotte RypensSteven J Van Laere
Breast Cancer Research and Treatment

Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients

Breast Cancer Research and TreatmentJanuary 22, 2020
Oluwadamilola M FayanjuE Shelley Hwang
Scientific Reports

Neutrophil activation causes tumor regression in Walker 256 tumor-bearing rats

Scientific ReportsNovember 13, 2019
Wilson Mitsuo Tatagiba KuwabaraJosé Cipolla-Neto
Journal of Translational Medicine

The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice

Journal of Translational MedicineNovember 30, 2019
Marina DegoricijaJanos Terzic
Frontiers in Oncology

Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors

Frontiers in OncologyJanuary 11, 2020
Maria Carolina Mangini PradoCarlos Eduardo Fonseca-Alves
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry

A Potential Anti-Tumor Herb Bred in a Tropical Fruit: Insight into the Chemical Components and Pharmacological Effects of Momordicae Semen

Molecules : a Journal of Synthetic Chemistry and Natural Product ChemistryNovember 7, 2019
Xiao-Rong XuDing-Kun Zhang

Oropharyngeal Colostrum Positively Modulates the Inflammatory Response in Preterm Neonates

NutrientsFebruary 9, 2020
Estefanía Martín-ÁlvarezJulio J Ochoa
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society

Thymoquinone (2-Isoprpyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects

Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical SocietyDecember 31, 2019
Anas AhmadRehan Khan
Anticancer Research

Prevalence and Characteristics of Pneumonitis Following Irradiation of Breast Cancer

Anticancer ResearchNovember 11, 2019
Elisa M WernerDirk Rades

See more papers from this feed

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

© 2020 Meta ULC. All rights reserved